Molecular mimicry in Guillain-Barré syndrome

Annals of the New York Academy of Sciences

Volumn 845, Issue , 1998, Pages 307-321

  Sheikh, K A ^a   Ho, T W ^a   Nachamkin, I ^b   Li, C Y ^c   Cornblath, D R ^a   Asbury, A K ^b   Griffin, J W ^a   Mckhann, G M ^a,d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Second Teaching Hospital   (China)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GANGLIOSIDE ANTIBODY; LIPOPOLYSACCHARIDE;

BACTERIAL INFECTION; CAMPYLOBACTER JEJUNI; CHINA; CONFERENCE PAPER; DEMYELINATION; ELECTRODIAGNOSIS; EUROPE; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOPATHOGENESIS; MOLECULAR MIMICRY; NERVE FIBER; NORTH AMERICA; PARALYSIS; PATHOGENESIS; PATHOLOGY; PERIPHERAL NERVE; SEROLOGY;

BACTERIA (MICROORGANISMS); CAMPYLOBACTER; CAMPYLOBACTER JEJUNI;

EID: 0031880308     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb09683.x     Document Type: Article

References (62)

1. HAFER-MACKO, C., S.-T. HSIEH, C. Y. LI, T. W. HO, K. A. SHEIKH, D. R. CORNBLATH, G. M. MCKHANN, A. K. ASBURY & J. W. GRIFFIN. 1996. Acute motor axonal neuropathy: An antibody-mediated attack on axolemma. Ann. Neurol. 40:635-644.
2. HAFER-MACKO, C., K. A. SHEIKH, C. Y. LI, T. W. HO, D. R. CORNBLATH, G. M. MCKHANN, A. K. ASBURY & J. W. GRIFFIN. 1996. Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann. Neurol. 39:625-635.
3. HO, T. W., B. MISHU, C. Y. LI, C. Y. GAO, D. R. CORNBLATH, J. W. GRIFFIN, A. K. ASBURY, M. J. BLASER & G. M. MCKHANN. 1995. Guillain-Barre syndrome in northern China: Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 118:597-605.
4. YUKI, N., S. HANDA, T. TAKI, T. KASAMA, M. TAKAHASHI & K. SAITO. 1992. Cross-reactive antigen between nervous tissue and a bacterium elicits Guillain-Barre syndrome: Molecular mimicry between gangliocide GM1 and lipopolysaccharide from Penner's serotype 19 of Campylobacter jejuni. Biomed. Res. 13:451-453.
5. YUKI, N., S. SATO, S. FUJIMOTO, Y. YAMADA, A. KINOSHITA & T. ITOH. 1992. Serotype of Campylobacter jejuni, HLA, and the Guillain-Barre syndrome. Muscle & Nerve 16: 968-969.
6. REES, J. H., N. A. GREGSON & R. A. C. HUGHES. 1995. Anti-ganglioside GM1 antibodies in Guillain-Barre syndrome and their relationship to Campylobacter jejuni infection. Ann. Neurol. 38:809-816.
7. OOMES, P. G., B. C. JACOBS, M. P. H. HAZENBERG, J. R. J. BANFFER & F. G. A. VAN DER MECHÉ. 1995. Anti-GM1 IgG antibodies and Campylobacter jejuni bacteria in Guillain-Barre syndrome: Evidence of molecular mimicry. Ann. Neurol. 38:170-175.
8. REES, J. H., S. E. SOUDAIN, N. A. GREGSON & R. A. HUGHES. 1995. Campylobacter jejuni infection and Guillain-Barre syndrome. N. Engl. J. Med. 333:1374-1379.
9. KUSUNOKI, S., A. CHIBA, K. KON, S. ANDO, K. ARISAWA, A. TATE & I. KANAZAWA. 1994. N-acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barre syndrome. Ann. Neurol. 35:570-576.
10. FUJIMOTO, S., N. YUKI, T. ITOH & K. AMAKO. 1992. Specific serotype of Campylobacter jejuni associated with Guillain-Barre syndrome. J. Infect. Dis. 165:183.
11. KUROKI, S., T. SAIDA, M. NUKINA, T. HARUTA, M. YOSHIOKA, Y. KOBAYASHI & H. NAKANISHI. 1993. Campylobacter jejuni strains from patients with Guillain-Barre syndrome belong mostly to Penner serogroup 19 and contain beta-N-acetylelucosamine residues. Ann. Neurol. 33:243-247.
12. ASPINALL, G. O., S. FUJIMOTO, A. G. MCDONALD, et al. 1994. Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barre syndrome patients mimic human gangliosides in structure. Infect. Immun. 62:2122-2125.
13. ASPINALL, G. O., A. G. MCDONALD, H. PANG, L. A. KURJANCZYK & J. L. PENNER. 1994. Lipopolysaccharides of Campylobacter jejuni serotype O:19: Structures of core oligosaccharide regions from the serostrain and two bacterial isolates from patients with the Guillain-Barré syndrome. Biochemistry 33:241-249.
14. TING-BEALL, H. P., M. B. LEES & J. D. ROBERTSON. 1979. Interactions of Folch-Lees proteolipid apoprotein with planar lipid bilayers. J. Membr. Biol. 51:33-46.
15. ASBURY, A. K. & D. R. CORNBLATH. 1990. Assessment of current diagnostic criteria for Guillain-Barre syndrome. Ann. Neurol. 27(Suppl.):S21-S24.
16. GRIFFIN, J. W., C. Y. LI, T. W. HO, P. XUE, C. MACKO, D. R. CORNBLATH, C. Y. GAO, C. YANG, M. TIAN, B. MISHU, et al. 1995. Guillain-Barre syndrome in northern China: The spectrum of neuropathologic changes in clinically defined cases. Brain 118:577-595.
17. GRIFFIN, J. W., C. Y. LI, T. W. HO, M. TIAN, C. Y. GAO, P. XUE, B. MISHU, D. R. CORNBLATH, C. MACKO, G. M. MCKHANN, et al. 1996. Pathology of the motor-sensory axonal Guillain-Barre syndrome. Ann. Neurol. 39:17-28.
18. BRECHENMACHER, C., C. VITAL, L. LAURENTJOYE & Y. CASTAING. 1981. Ultrastructural study of peripheral nerve in Guillain-Barre syndrome. Presence of mononuclear cells in axons. Acta Neuropathol. 7(Suppl.):249-251.
19. GRIFFIN, J. W., C. Y. LI, C. MACKO, T. W. HO, S.-T. HSIEH, P. XUE, F. A. WANG, D. R. CORNBLATH, G. M. MCKHANN & A. K. ASBURY. 1996. Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barre syndrome. J. Neurocytol. 25:33-51.
20. 1a antibodies. Muscle & Nerve 15:899-903.
21. 1 antibodies following Campylobacter jejuni enteritis. Neurology 40:1900-1902.
22. YUKI, N., S. SATO, S. TSUJI, T. OHSAWA & T. MIYATAKE. 1993. Frequent presence of anti-GQ1b antibody in Fisher's syndrome. Neurology 43:414-417.
23. JACOBS, B. C., H. ENDTZ, F. G. A. VAN DER MECHÉ, M. P. HAZENBERG, H. A. ACHTEREEKTE & P. A. VAN DOORN. 1995. Serum anti-GQ1b IgG antibodies recognize surface epitopes on Campylobacter jejuni from patients with Miller Fisher syndrome. Ann. Neurol. 37:260-264.
24. YUKI, N., T. TAKI & S. HANDA. 1996. Antibody to Ga1NAc-GD1a and Ga1NAc-GM1b in Guillain-Barre syndrome subsequent to Campylobacter jejuni enteritis. J. Neuroimmunol. 71:155-161.
25. CHIBA, A., S. KUSUNOKI, T. SHIMIZU & I. KANAZAWA. 1992. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann. Neurol. 31:677-679.
26. WILLISON, H. J., J. VEITCH, G. PATTERSON & P. G. E. KENNEDY. 1993. Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside. J. Neurol. Neurosurg. Psychiatry 56:204-206.
27. GREGSON, N. A., S. KOBLAR & R. A. C. HUGHES. 1993. Antibodies to gangliosides in Guillain-Barre syndrome: Specificity and relationship to clinical features. Q. J. Med. 86:111-117.
28. VRIESENDORP, F. J., B. MISHU, M. BLASER & C. L. KOSKI. 1993. Serum antibodies to GM1, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barre syndrome and controls: Correlation and prognosis. Ann. Neurol. 34:130-135.
29. ENDERS, U., H. KARCH, K. V. TOYKA, M. MICHELS, J. ZIELASEK, M. PETTE, J. HEESEMANN & H.-P. HARTUNG. 1993. The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barre syndrome and in other neuroimmunological disorders. Ann. Neurol. 34:136-144.
30. VISSER, L. H., F. G. A. VAN DER MECHÉ, P. A. VAN DOORN, et al. 1995. Guillain-Barré syndrome without sensory loss (acute motor neuropathy): A subgroup with specific clinical, electrodiagnostic and laboratory features. Brain 118:841-847.
31. YUKI, N., T. TAKI, F. INAGAKI, et al. 1993. A bacterium lipopolysaccharide that elicits Guillain-Barre syndrome has a GM1 ganglioside-like structure. J. Exp. Med. 178:1771-1775.
32. 1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher's syndrome. Ann. Neurol. 36:791-793.
33. JACOBS, B. C., M. P. HAZENBERG, P. A. VAN DOORN, H. P. ENDTZ & F. G. A. VAN DER MECHÉ. 1997. Cross-reactive antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in patients with Guillain-Barré or Miller Fisher syndrome. J. Infect. Dis. 175:729-733.
34. MISHU, B., A. A. ILYAS, C. L. KOSKI, F. VRIESENDORP, S. A. COOK, F. MITHEN & M. J. BLASER, 1993. Serologic evidence of previous Campylobacter jejuni infection in patients with the Guillain-Barre syndrome. Ann. Intern. Med. 118:947-953.
35. HO, T., C. LI, D. CORNBLATH, C. GAO, A. ASBURY, J. GRIFFIN & G. MCKHANN. 1997. Patterns of recovery in the Guillain-Barre syndromes. Neurology 48:695-700.
36. WILLISON, H. J., G. PATERSON, P. G. KENNEDY & J. VEITCH. 1994. Cloning of human anti-GM1 antibodies from motor neuropathy patients. Ann. Neurol. 35:471-478.
37. YUKI, N., M. YAMADA, S. SATO, E. OHAMA, Y. KAWASE, F. IKUTA & T. MIYATAKE. 1993. Association of IgG anti-GD1a antibody with severe Guillain-Barre syndrome. Muscle & Nerve 16:642-647.
38. MARCUS, D., N. LATOV & B. HSI. 1989. Measurement and significance of antibodies against GM1 ganglioside. J. Neuroimmunol. 25:255-259.
39. ZIELASEK, J., G. RITTER, S. MAGI, H. HARTUNG & K. TOYKA. 1994. A comparative trial of anti-glycoconjugate antibody assays IgM antibodies to CM1. J. Neurol. 241:475-480.
40. WILLISON, H. 1994. Antiglycolipid antibodies in peripheral neuropathy: Fact or fiction? J. Neurol. Neurosurg. Psychiatry 57:1303-1307.
41. FREDMAN, P. 1998. The role of antiglycolipid antibodies in neurologic disorders. This issue.
42. BAUMANN, N., M.-L. HARPIN, Y. MARIE, K. LEMERLE, B. CHASSANDE, P. BOUCHE, V. MEININGER, R. K. YU & J.-M. LEGER. 1998. Antiglycolipid antibodies in motor neuropathies. This issue.
43. YUKI, N., T. TAKI, M. TAKAHASHI, et al. 1994. Penner's serotype 4 of Campylobacter jejuni has a lipopolysaccharide that bears a GM1 ganglioside epitope as well as one that bears a GD1a epitope. Infect. Immun: 62:2101-2103.
44. PENNER, J. L. & J. N. HENNESSY. 1980. Passive hemagglutination techniques for serotyping Campylobacter fetus subsp. jejuni on the basis of soluble heat-stable antigens. J. Clin. Microbiol. 12:732-737.
45. PRESTON, M. A. & J. L. PENNER. 1987. Structural and antigenic properties of lipopolysaccharides from serotype reference strains of Campylobacter jejuni. Infect. Immun. 55:1806-1812.
46. ASPINALL, G. O., A. G. MCDONALD, T. S. RAJU, H. PANG & A. P. MORAN. 1993. Chemical structures of the core regions of Campylobacter jejuni serotypes O:1, O:4, O:23, and O:36 lipopolysaccharides. Eur. J. Biochem. 213:1017-1027.
47. TAUXE, R. V., I. NACHAMKIN, M. J. BLASER & L. S. TOMPKINS, Eds. 1992. Campylobacter jejuni: Current Status and Future Trends. Epidemiology of Campylobacter jejuni Infections in the United States and Other Industrialized Nations: 9-19. American Society for Microbiology. Washington, D.C.
48. MISHU, B. & M. J. BLASER. 1993. Role of Infection due to Campylobacter jejuni in the initiation of Guillain-Barre syndrome. Clin. Infect. Dis. 17:104-108.
49. LIOR, H., D. L. WOODWARD, J. A. EDGAR, L. J. LAROCHE & P. GILL. 1982. Serotyping of Campylobacter jejuni by slide agglutination based on heat labile antigenic factors. J. Clin. Microbiol. 15:761-768.
50. NACHAMKIN, I., K. BOHACHICK & C. M. PATTON. 1993. Flagellin gene typing of Campylobacter jejuni by restriction fragment length polymorphism analysis. J. Clin. Microbiol. 31:1531-1536.
51. NACHAMKIN, I., H. UNG & C. M. PATTON. 1996. Analysis of HL and O serotypes of Campylobacter by the fiagellin gene typing system. J. Clin. Microbiol. 34:277-281.
52. WESTPHAL, O. & K. JANN. 1965. Bacterial lipopolysaccharides: Extraction with phenolwater and further applications of the procedure. Methods Carbohdr. Chem. 5:83-91.
53. SACKS, J. J., S. LIEB, L. M. BALDY, S. BERTA, C. M. PATTON, M. C. WHITE, W. J. BIGLER & J. J. WITTE. 1986. Epidemic Campylobacteriosis associated with a community water supply. Am. J. Public Health 76:424-429.
54. YUKI, N., M. TAKAHASHI, Y. TAGAWA, K. KASHIWASE, K. TADOKORO & K. SAITO. 1997. Association of Campylobacter jejunni serotype with antiganglioside antibody in Guillain-Barre syndrome and Fisher's syndrome. Ann. Neurol. 42:28-33.
55. VON WULFFEN, H., C. HARTARD & E. SCHAREIN. 1994. Seroreactivity to Campylobacter jejuni and gangliosides in patients with Guillain-Barre syndrome. J. Infect. Dis. 170:828-833.
56. REES, J. H., N. A. GREGSON & R. A. HUGHES. 1995. Anti-ganglioside antibodies in patients with Guillain-Barré syndrome and Campylobacter jejuni infection. J. Infect. Dis. 172:605-606.
57. WILLISON, H. J. & J. VEITCH. 1994. Immunoglobulin subclass distribution and binding characteristics of anti-GQ1b antibodies in Miller Fisher syndrome. J. Neuroimmunol. 50:159-165.
58. SHEIKH, K. A., T. J. DEERINCK, J. W. GRIFFIN & M. ELLISMAN. 1998. Submitted for publication.
59. O'HANLON, G. M., G. J. PATERSON, G. WILSON, et al. 1996. Anti-GM1 ganglioside antibodies cloned from autoimmune neuropathy patients show diverse binding patterns in the rodent nervous system. J. Neuropathol. Exp. Neurol. 55:184-195.
60. HO, T., S. HSIEH, I. NACHAMKIN, H. WILLISON, K. SHEIKH, J. KIEHLBAUCH, K. FLANIGAN, J. MCARTHUR, D. CORNBLATH, G. MCKHANN, et al. 1997. Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after Campylobacter infection. Neurology 48:717-724.
61. YUKI, N., S. SATO, T. ITOH & T. MIYATAKE. 1991. HLA-B35 and acute axonal polyneuropathy following Campylobacter jejuni infection. Neurology 41:1561-1563.
62. REES, J. H., R. W. VAUGHAN, E. KONDEATIS & R. A. C. HUGHES. 1995. HLA-class II alleles in Guillain-Barre syndrome and Miller Fisher syndrome and their association with preceding Campylobacter jejuni infection. J. Neuroimmunol. 62:53-57.